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Introduction
Chronic obstructive pulmonary disease is a progressive 
condition characterised by airflow limitation which is 
not fully reversible (WHO). Dyspnoea, excessive sputum 
production, and chronic cough are the most common 
symptoms. It is estimated that 3 million people died of 
chronic obstructive pulmonary disease in 2005 and WHO 
predicts that it will be the fourth leading cause of death 
world wide by 2030 (WHO). Management of stable chronic 
obstructive pulmonary disease includes pharmacotherapy 
for relief of symptoms, pulmonary rehabilitation programs 
for health education, and exercise to improve exercise 
tolerance and dyspnoea (GOLD 2007). Adverse effects of 
medications have encouraged alternative approaches to 
management of patients with chronic illness. Acupuncture 
has been reported as an alternative mode of management for 
breathlessness (dyspnoea) in oncology patients (Cohen et al 
2005, Pan et al 2000) as well as in patients with respiratory 
disease (Davis et al 2001, Jobst et al 1986, Lewith et al 
2004). A review of 16 randomised control trials, involving 
2937 participants, concluded that acupuncture is a safe and 
potentially-effective intervention for patients with asthma 
and chronic obstructive pulmonary disease (Jobst 1995).
Acupuncture is invasive and therefore carries some risk 
of injury (Lao et al 2003, Peuker and Gronemeyer 2001, 
Vilke and Wulfert 1997). Application of transcutaneous 
electrical nerve stimulation, a non-invasive modality, over 
specific acupoints (Acu-TENS) is believed to elicit similar 
responses to manual acupuncture in pain relief (Grant et 
al 1999, Kerr et al 2003, Ng et al 2003). Acu-TENS can 
be administered by the patient or their carers and if proven 
to be effective, may assist control of dyspnoea and thereby 
promote quality of life in patients with chronic obstructive 
pulmonary disease. The effect of Acu-TENS on dyspnoea 
has not been reported for any population.
The research question in this study of patients with stable 
chronic obstructive pulmonary disease was:
What is the immediate effect of a single 45-minute 
session of Acu-TENS on lung function and dyspnoea?
Method
Design
A randomised, placebo-controlled, pre-test and post-test 
design was carried out and the STRICTA recommendations 
were followed (MacPherson et al 2002). Ambulatory elderly 
(over 60 years of age) citizens with a medical diagnosis 
of chronic obstructive pulmonary disease and attending 
pulmonary rehabilitation programmes at community centres 
were referred by social workers. Eligible participants were 
then randomly assigned to either the experimental (Acu-
TENS) or control (placebo-TENS) group. Randomisation 
was by block mode to ensure even numbers between groups. 
Numbers were placed in sealed opaque envelopes before the 
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beginning of the trial so that randomisation was concealed 
from the recruiter. A sealed opaque envelope was given 
to the patient and opened by the investigator who applied 
the interventions. Participants rested for 30 minutes after 
which lung function and dyspnoea were measured. All 
participants then received 45 minutes of either Acu-TENS or 
placebo-TENS. Participants in the control group were told 
that the stimulation frequency selected was not perceivable 
by humans so participants were blind to group allocation. 
One investigator was responsible for the application of 
both interventions. Then, lung function and dyspnoea were 
measured again. Data collection and entry was performed 
by a person blinded to group allocation.
Participants
Patients were included if they had a diagnosis of stage I 
or II chronic obstructive pulmonary disease according 
to the GOLD classification (GOLD 2001), an ability to 
communicate, and were independent in mobility with or 
without a walking aid. They were excluded if they had 
co-existing ischaemic heart disease, a cardiac pacemaker, 
diabetes mellitus, a neurological deficit, poor perception and/
or cognitive function, an acute exacerbation of obstructive 
airways disease within one month prior to data collection, or 
had previously received TENS or acupuncture. Participants 
were also excluded from the study if they had received a 
bronchodilator less than 6 hours prior to data collection. 
Demographic data such as age, gender, smoking history and 
medication were recorded.
Intervention
The experimental group received 45 minutes of Acu-TENS 
at bilateral acupoints Ex-B1 (known as Ding Chuan in 
Traditional Chinese Medicine), located at 0.5 ‘cun’ lateral to 
the spinous process of 7th cervical vertebra, where 1 cun is the 
distance between the medial creases of the interphalangeal 
joints of an individual’s middle finger. Ex-B1 was chosen 
since it is the point most commonly reported in the Chinese 
literature for management of shortness of breath (Ngai et al 
2006). Once determined, each acupoint was cleaned with 
an alcohol swab to reduce resistance to passage of current 
and marked. A non-conductive plastic film 50 x 50 mm2 
was punctured in the middle creating a pore of diameter 
0.79 mm. This film was then placed over the participant’s 
skin, with the pore directly over the marked acupoint. A 50 
x 50 mm2 electrode was then placed over each plastic film 
(Figure 1). This configuration restricts electrical stimulation 
to the acupoint only. The bilateral electrodes were attached 
to a TENS machinea. Stimulation was at a frequency of 4 
Hz and pulse width 200 microseconds. Intensity was set at 
the highest tolerable by the participant short of discomfort. 
Reliability of voltage output of the machine was tested using 
a laboratory oscilloscope prior to data collection.
The control group received 45 minutes of placebo-TENS. A 
plastic film with no central pore was placed on the skin over 
each marked acupoint. Participants could see the output 
light flashing but no current was transmitted to the acupoint 
throughout the 45 minutes. Prior to data collection, the 
absence of electrical stimulation employed by this method 
was affirmed in five participants.
Outcome measures
Lung function was measured as forced expiratory volume in 
1 second (FEV1) and forced vital capacity (FVC) according 
to the American Thoracic Society recommendations 
(American Thoracic Society 1995) using a spirometerb 
calibrated with a 3-litre super syringe. All measurements 
were performed in the sitting position and the best of 3 trials 
was recorded. Dyspnoea was measured using a shortness 
of breath 100-mm visual analogue scale (Martinez et al 
2000) where zero represented ‘not breathless at all’ and 100 
mm represented ‘the worst breathless sensation you ever 
experienced’.
Data analysis
The clinical significance of the effect of Acu-TENS is 
reported as mean difference (95% CI) while the statistical 
significance is reported as p values from independent t-tests. 
Analysis was by intention-to-treat. A statistical significance 
level was set at p < 0.05.
Results
Flow of participants through the trial
A total of 46 participants (31 male and 15 female) from 4 
community centres for the elderly met the inclusion criteria. 
The mean age was 75 years (SD 7), mean BMI was 23.6 
kg/m2 (SD 4.4); predicted FEV1 was 69% (SD 14) and 
predicted FVC was 73% (SD 13). Fifteen participants (33%) 
were ex-smokers (ie, they had stopped smoking for over 
12 months), 22 (48%) were current smokers, and 9 (20%) 
were non-smokers. Age, BMI, % predicted FEV1 and FVC 
Figure 1. a) Identification of acupuncture points EX-B1.  
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were similar between the two groups (Table 1). Medications 
prescribed were: Beclazone (250 mcg), theophylline 
(200 mcg/300mg), Ventolin (1–4 puffs), and/or Atrovent/
Combivent (1–2 puffs) as required. Medication for both 
groups was similar and none of the 46 participants received 
bronchodilators less than 6 hours prior to lung function 
measurements.
Compliance with trial method
All participants who met the inclusion criteria completed 
the trial. There was no report of adverse effects. All 
participants completed the post-intervention measurements, 
and all participants’ data were included in the intention-to-
treat analysis.
Effect of intervention
Group data as well as within- and between-group data are 
presented in Table 2 while individual data are presented in 
Table 3 (see eAddenda for Table 3). After 45 minutes of 
Acu-TENS, the experimental group had increased their 
FEV1 by 0.12 litres (95% CI 0.07 to 0.15, p < 0.001) more 
than the control group. They had increased their FVC by 
0.05 litres (95% CI –0.01 to 0.10, p = 0.09) non-significantly 
more than the control group. Their shortness of breath had 
decreased by 11 mm on the 100-mm visual analogue scale 
(95% CI –14 to –8) more than the control group.
Discussion
Comparison with previous studies
This study showed that a single session of bilateral application 
of TENS to acupoint EX-B1 (Ding Chuan) for 45 minutes 
in patients with chronic obstructive pulmonary disease 
increased FEV1 and decreased dyspnoea. Positive effects 
of acupuncture and acupressure on dyspnoea management 
have been reported previously. Maa and colleagues (1997) 
showed that self-administered acupressure (kneading 
and pressure) over 7 acupoints (1 to 2 minutes per point) 
for 6 weeks reduced dyspnoea in patients with chronic 
obstructive pulmonary disease. Wu and colleagues (2004) 
showed that, compared to sham acupressure, acupressure 
over 5 acupoints (different from those reported in Maas’s 
study) for 3 minutes, 5 sessions per week for 4 weeks 
decreased dyspnoea (measured by the Modified Pulmonary 
Function Status and Dyspnoea Questionnaire), improved 
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walking capacity, and reduced anxiety. Maa’s group (2003) 
also compared the effect of acupuncture and acupressure 
on dyspnoea and quality of life in participants with chronic 
obstructive asthma and found that patients who received 
acupuncture reported an 18-fold improvement in the St 
George’s Respiratory Questionnaire score compared with 
a 6-fold improvement in patients who received acupressure. 
While our findings of decreased dyspnoea are similar 
to previous studies, direct comparison is not possible 
because previous studies investigated the effect of needle 
acupuncture, acupressure, and even moxibustion (burning 
of herbs over certain acupuncture points) (Jobst et al 1986) 
as part of the intervention. Furthermore, acupuncture points 
were not standardised in many of the studies and duration 
of intervention varied between studies. A combination 
of points was used in many studies as some points were 
believed to improve the flow of energy (Qi) as well as 
decrease dyspnoea whereas in our study, the stimulation of 
Ex-B1 was standardised.
St George’s Respiratory Questionnaire (Lewith et al 
2004), the Pulmonary Function Status and Dyspnoea 
Questionnaire (Wu et al 2004), the Shuttle Test (Davis et 
al 2001) and the 6-min Walk Test (Maa et al 2003) have all 
been used to evaluate the effect of acupuncture on dyspnoea 
in patients with chronic obstructive pulmonary disease. 
Most studies reported a positive effect of acupuncture 
on dyspnoea, but whether acupuncture improved quality 
of life in patients with chronic obstructive pulmonary 
disease remains controversial. While Maa’s group (2003) 
showed that the St George’s Respiratory Questionnaire 
score improved significantly more after acupuncture than 
acupressure, Lewith and colleagues (2004) reported that 
the improvement in St George’s Respiratory Questionnaire 
scores did not differ significantly from the effect of sham 
TENS (no electrical output). Davis and colleagues (2001) 
commented that the Shuttle Test was ‘impractical in a 
domiciliary environment’ because most patients lacked 
a 10-m flat space at their residence (Davis et al 2001). 
Furthermore, while these measures may be appropriate for 
evaluation of the effect of long-term acupuncture, they may 
not be sufficiently sensitive to evaluate the effect of a single 
acupuncture session.
Mechanism of effect of acupuncture on 
dyspnoea
According to traditional Chinese medicine, dyspnoea 
results from a deficiency in the flow of ‘Qi’ (energy) in the 
lungs (Xu and Tan 1988) and application of an appropriate 
acupuncture technique is thought to restore the ‘Qi 
balance’. This concept led to the use of a combination of 
points including those that were believed to restore energy 
and improve the flow of Qi (Maa et al 1997). However a 
satisfactory explanation of Qi flow and balance according 
to western medicine, has not yet been described (Tan and 
Horn 1998). Western medicine hypothesises that signals 
from stimulation of peripheral nerve fibres (possibly 
through acupuncture points) can influence hypothalamic 
functions via the dorsal periaqueductal grey fibres, and 
thereby influence the respiratory centre in the medulla, 
modifying respiration (Takeshige et al 1993). Investigation 
of the relationship between acupuncture and neural activity 
has been reported. Stimulation of vision-related acupoints 
has been shown to be associated with activation of the 
occipital lobe using functional magnetic resonance imaging 
(Cho et al 1998). Electroencephalography has been used to 
demonstrate a relationship between acupuncture and brain 
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activity (Rosted et al 2001). There is also speculation that 
the decrease in dyspnoea resulting from acupuncture is 
mediated by endogenous opiate release as a consequence of 
hypothalamic stimulation (Jobst et al 1986). Indeed, opiates 
are prescribed as respiratory depressants to modulate the 
sensation of breathlessness (Bellofiore et al 1990).
Dyspnoea in patients with chronic obstructive pulmonary 
disease has been associated with increased bronchial 
and systemic inflammation (Bhowmik et al 2000, Hill 
et al 1999, Roland et al 2001) and changes in levels of 
inflammatory mediators such as tumour necrosis factor and 
interleukin-8 have been associated with airflow limitation 
(Wouters 2002). Inflammation leads to a rise in cytokine 
levels, which are transmitted to the hypothalamus via 
sensory nerve transmission (Maier et al 1998). An efferent 
signal from the hypothalamus via parasympathetic nerves 
causes a release of acetylcholine at the parasympathetic 
nerve endings, evoking a suppressive effect on the release of 
the inflammatory cytokines (Tracey 2002). Increased levels 
of cytokines may also directly activate the hypothalamus-
pituitary-adrenal axis via the vagus nerve, inducing the 
release of glucocorticocoids, further suppressing cytokine 
synthesis (Cho et al 2006, Maier et al 1998, Tracey 2002). 
Acupuncture is thought to evoke a suppressive effect on 
inflammatory mediator levels either via afferent (pre-
synaptic) or efferent (post-synaptic) vagus nerve stimulation 
(Cho et al 2006) thereby decreasing dyspnoea. However, a 
direct effect of acupuncture on inflammatory markers in 
patients with chronic obstructive pulmonary disease has yet 
to be shown.
Mechanism of effect of Acu-TENS on dyspnoea
Application of TENS, at a tolerable intensity in humans, 
has been shown to stimulate Aα and Aβ nerve fibres (Levin 
and Hui-Chan 1993). We hypothesised that the application 
of TENS over acupoints may induce signal transmission 
similar to acupuncture, influencing vagal afferents via 
hypothalamic stimulation. However, determining whether 
the decrease in dyspnoea was a result of hypothalamic 
activity associated with endorphin release was beyond 
the scope of our study. The physiological mechanism 
underlying dyspnoea is complex and further investigation 
of the association between Acu-TENS and endorphin levels 
on dyspnoea is warranted.
Clinical implication of the application of  
Acu-TENS on lung function
This study found that FEV1 increased by 10% (ie, 120 ml) 
more after Acu-TENS than placebo-TENS. While there is 
no complete agreement on standard criteria for evaluation 
of a short-term response to a bronchodilator (Tashkin et al 
2008), the common indicators used to express a positive 
response to a bronchodilator are ≥ 15% improvement over 
pre-bronchodilator FEV1 (ACCP 1974); ≥ 12% improvement 
plus an absolute volume increase of ≥ 200ml (Pellegrino 
et al 2005) and an absolute improvement over pre-
bronchodilator FEV1 of ≥ 10% predicted value (Anthonisen 
and Wright 1986). The improvement of FEV1 in this study 
did not reach these standards, however direct comparison 
between effects of bronchodilators and Acu-TENS may 
not be appropriate. It is believed that bronchodilators 
decrease dyspnoea by reducing residual volume (air-
trapping) (Price et al 2004). Bronchodilators are chemicals 
that specifically target reversible bronchoconstriction 
through neuromuscular transmission at receptors over the 
airways, inducing relaxation of airway smooth muscle. 
The proposed effect of Acu-TENS on FEV1 is through 
central processing of neural signals whereas its action on 
airways, if any, is indirect. Furthermore, acute dyspnoea 
ratings and changes in FEV1 are not necessarily linear, and 
a decrease in dyspnoea does not correlate with an increase 
in FEV1 (O’Donnell et al 1997). Although the improvement 
in FEV1 demonstrated in this study did not reach the gold 
standard set for ‘bronchodilator’ evaluation, this study 
revealed that Acu-TENS improved FEV1 by 10% more than 
placebo-TENS, which is very close to the ‘≥ 10% predicted 
value’ standard proposed (Anthonisen and Wright 1986). 
Furthermore, a decrease in dyspnoea score by 13% more 
than placebo-TENS should not be underestimated.
This study found Acu-TENS improved FVC by only 3% 
(ie, 50 ml) over placebo-TENS which was statistically 
insignificant. The total volume of air exhaled during forced 
expiration should increase when airway narrowing is less, 
but with one session of Acu-TENS, a clinically-significant 
change in FVC was not expected.
Limitations of the study
This study has several limitations. First, the severity of 
chronic obstructive pulmonary disease of the participants 
Table 2. Mean (SD) for each group, mean (SD) difference within groups, and mean (95% CI) difference between groups for 
lung function and dyspnoea for the experimental group (n = 23) and the control group (n = 23).
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FEV1= forced expiratory volume in 1 second; FVC = forced vital capacity; SOB VAS = shortness of breath visual analogue scale;  
Exp = experimental, Con = control
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was moderate. Even though the participants reported a mean 
dyspnoea score as high as 80 on a 100-mm visual analogue 
scale, the high end anchor of our visual analogue scale 
was ‘the worst breathless sensation ever experienced’. Our 
predictive values were based on Lam’s sample of Chinese 
participants (Lam et al 1982). If our predictive values 
were based on a European data base (Roca et al 1986), the 
predicted FEV1 of our participants would be 50% which 
would categorise them very close to severe (GOLD 2007). 
Most participants travelled to the centre by bus and had to 
walk some distance to the community centre. Participants 
who took part in the study were those who did not take 
their bronchodilator on the day of assessment. Although 
they were allowed 30 minutes of rest before measurement 
of lung function, this may not have been sufficient for their 
dyspnoea to return to normal resting levels. Therefore, it 
may not be appropriate to extrapolate our findings to patients 
with mild chronic obstructive pulmonary disease and 
moderate dyspnoea. It should however be noted that if the 
expected effect of acupuncture is to maintain homeostasis, 
the effect of Acu-TENS on patients might be more dramatic 
on patients with high but not low level of dyspnoea. 
Second, this study focused on the effect of a single session 
of Acu-TENS in chronic obstructive pulmonary disease 
patients and the potential long term effects of Acu-TENS 
on dyspnoea were not explored. Third, we compared the 
effect of TENS or placebo-TENS over acupuncture points 
rather than TENS applied over non acupuncture points and 
therefore we are unable to draw conclusions on whether the 
positive effect of Acu-TENS was in fact acupoint-specific 
or a general effect of TENS. Fourth, we did not measure 
quality of life, although function is related to dyspnoea and 
determines quality of life.
This study demonstrated that, compared to placebo-TENS 
with no electrical stimulation, bilateral application of 
Acu-TENS at acupuncture point EX-B1 for 45 minutes in 
ambulatory patients with chronic obstructive pulmonary 
disease lead to an improvement in dyspnoea and FEV1. TENS 
is a non-invasive, user-friendly, low cost, electrotherapy 
modality, and the application of Acu-TENS may assist 
dyspnoea management in patients with chronic obstructive 
pulmonary disease with the potential to improve activity 
levels and quality of life. The encouraging effect of Acu-
TENS in our patient cohort suggests that Acu-TENS may 
be a useful adjunctive intervention in the management of 
dyspnoea in patients with chronic obstructive pulmonary 
disease. The effect of Acu-TENS on endorphin levels, its 
combined effect with medication on dyspnoea, its effect 
on frequency or intensity of disease exacerbation, and 
its long-term effect on the quality of life in patients with 
chronic obstructive pulmonary disease, warrant further 
investigation.
Footnotes: aNeuroTrac, model CE 0120, Verity Medical 
LTD, England, UK. bPony spirometer graphic, COSMED, 
Italy.
eAddenda: Table 3 available at www.physiotherapy.asn.au/AJP.
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